Clinical effects of creatinol-O-phosphate in patients with heart diseases
Piancone, R.M.
Minerva Cardioangiologica 19(9): 462-474
1971
ISSN/ISBN: 0026-4725 PMID: 4106470 Document Number: 33601
Document emailed within 1 workday
Related Documents
Cucchini, F.; Colla, B.; Di Donato, M.; Visioli, O. 1978: Effects of creatinol-O-phosphate on left ventricular function in coronary disease patients Bollettino Della Societa Italiana di Cardiologia 23(3): 527-532Musso, E.; De Ambroggi, L.; Taccardi, B. 1974: Action of creatinol-O-phosphate and ouabain on automatic sinus activity in the isolated frog heart Il Farmaco; Edizione Pratica 29(11): 629-635
Ferrini, R.; Miragoli, G. 1975: Effects of creatinol O-phosphate on the isolated rabbit's atrium and on the rat's phrenic nerve diaphragm preparation Il Farmaco; Edizione Scientifica 30(11): 912-916
Marzo, A.; Ghirardi, P.; Croce, G. 1972: Pharmacokinetics of creatinol-o-phosphate La Clinica Terapeutica 62(5): 419-430
Sardini, D.; Marzo, A.; Ghirardi, P. 1971: Qualitative and quantitative determination of creatinol o-phosphate Il Farmaco; Edizione Pratica 26(3): 194-202
Silverman, B.D.; Merrill, A.J.; Gerber, L. 1985: Clinical effects and side effects of amrinone. a study of 24 patients with chronic congestive heart failure Archives of Internal Medicine 145(5): 825-829
Clausen, J.P.; Trap-Jensen, J. 1970: Effects of condition training on circulation in patients with arteriosclerotic heart diseases Nordisk Medicin 84(33): 1059
Oganov, R.G.; Gratsianskiĭ, N.A.; Mazur, N.A.; Lazebnik, L.B.; Belousov, I.B.; Sidorenko, B.A.; Ol'binskaia, L.I.; Vertkin, A.L.; Shevchenko, O.P.; Karpov, I.A. 1992: Circadian rhythm in the clinical course of cardiovascular diseases. Clinical experience using Norvasc (amlodipine) in the treatment of patients with ischemic heart disease and arterial hypertension Kardiologiia 32(5): 99-112
Toronchenko, O.M. 2000: Characteristics of the clinical course of ischemic heart diseases in patients with hypertensive dyscirculatory encephalopathy Likars'ka Sprava 6: 57-61
Malinovskiĭ, N.N.; Golubev, I.S.; Tarichko, I.V. 1971: Use of ethacrynic acid in the surgical clinical aspects of patients with rheumatic heart diseases and circulatory insufficiency Sovetskaia Meditsina 34(4): 118-122
Zou, H.-d.; Zhou, Q.-s.; Xia, W.-f.; Wu, L.-x.; Cheng, B.-c. 2007: Cardioprotective effects of propofol and midazolam in children with congenital heart diseases undergoing open heart surgery Zhonghua Yi Xue Za Zhi 87(33): 2309-2312
Simonian, A.T.; Melik-Adamian, A.A.; Topchian, A.A.; Parsian, S.D. 1973: Clinical use of cypenam and a technique of individual dose treatment of patients with nonspecific diseases of the lungs and pulmonary heart disease Terapevticheskii Arkhiv 45(3): 89-93
Ersoy, F.; Tezcan, I.; Sanal, O. 1992: Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases Turkish Journal of Pediatrics 34(4): 203-209
Nishio, S.; Kishimoto, T.; Maekawa, M.; Kawakita, J.; Hayahara, N.; Yuki, K.; Morikawa, Y.; Yasumoto, R.; Kato, Y.; Funai, K. 1986: Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer Hinyokika Kiyo. Acta Urologica Japonica 32(11): 1763-1770
Kemp, G.J.; Bevington, A.; Russell, R.G. 1988: Erythrocyte phosphate metabolism and pH in vitro: a model for clinical phosphate disorders in acidosis and alkalosis Mineral and Electrolyte Metabolism 14(5): 266-270
Rizzo, A.; Mecca, D. 1973: Heart disease patients in a modern hospital. Statistical studies with regard to the incidence of heart diseases among hospitalized patients in Ospedale S. Carlo from Jan 1, 1969 to Nov 10, 1969 Minerva Medica 64(52): 2733-2735
Ageev, F.T.; Zhubrina, E.S.; Ovchinnikov, A.G.; Seredenina, E.M. 2010: Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice Kardiologiia 50(6): 41-47
Freĭdlin, I.S.; Shcherbak, I.G.; Freĭdlin, T.S.; Safronnikov, L.V. 1986: Activation of glucose-6-phosphate dehydrogenase in mouse peritoneal macrophages by sera from patients with ischemic heart disease Biulleten' Eksperimental'noi Biologii i Meditsiny 101(6): 658-660
Eckert, W. 1988: What does the Heart Group achieve in the management of patients with chronic heart diseases? Versicherungsmedizin 40(1): 24-28
Prakanrattana, U.; Valairucha, S.; Sriyoschati, S.; Pornvilawan, S.; Phanchaipetch, T. 1997: Early extubation following open heart surgery in pediatric patients with congenital heart diseases Journal of the Medical Association of Thailand 80(2): 87-95